Timber Hill’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-4,018
Closed -$302K 500
2017
Q4
$302K Sell
4,018
-12,164
-75% -$918K 0.02% 487
2017
Q3
$1.25M Sell
16,182
-10,714
-40% -$809K 0.12% 157
2017
Q2
$2.01M Sell
26,896
-24,775
-48% -$1.76M 0.08% 212
2017
Q1
$3.44M Sell
51,671
-18,972
-27% -$1.26M 0.02% 487
2016
Q4
$4.61M Sell
70,643
-64,505
-48% -$4.18M 0.02% 555
2016
Q3
$9.56M Sell
135,148
-70,866
-34% -$5.16M 0.05% 322
2016
Q2
$15.2M Buy
206,014
+162,602
+375% +$11.2M 0.07% 233
2016
Q1
$2.82M Sell
43,412
-28,347
-40% -$1.93M 0.01% 762
2015
Q4
$5.53M Sell
71,759
-100,328
-58% -$7.97M 0.03% 509
2015
Q3
$14.2M Sell
172,087
-50,890
-23% -$4.53M 0.06% 259
2015
Q2
$19.6M Buy
222,977
+106,243
+91% +$9.75M 0.09% 196
2015
Q1
$10.3M Sell
116,734
-111,376
-49% -$9.88M 0.05% 333
2014
Q4
$18.9M Buy
228,110
+155,012
+212% +$12.8M 0.08% 208
2014
Q3
$6.17M Sell
73,098
-45,086
-38% -$3.65M 0.03% 518
2014
Q2
$9.59M Sell
118,184
-54,126
-31% -$4.26M 0.04% 344
2014
Q1
$13.1M Sell
172,310
-120,082
-41% -$8.75M 0.06% 279
2013
Q4
$21.1M Sell
292,392
-117,068
-29% -$8.14M 0.08% 206
2013
Q3
$28.1M Sell
409,460
-9,598
-2% -$635K 0.1% 163
2013
Q2
$26.6M Buy
+419,058
New +$27.3M 0.1% 171

Other funds holding NVS

Timber Hill's NVS Position: Q2 2018 in Review

Timber Hill sold out of Novartis (NVS) in Q2 2018, closing a stake of 9,833 shares — an estimated $712K sold.

Timber Hill first reported a position in NVS in Q4 2014 and held it in 9 quarters. The position peaked at $4.41M in Q1 2016. 987 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

  • Timber Hill reported no remaining Novartis position as of Q2 2018 after selling out during the quarter.
  • Timber Hill sold 9,833 Novartis shares in Q2 2018, an estimated $712K.
  • Timber Hill first reported a position in Novartis in Q4 2014 and held it in 9 quarters.
  • Timber Hill's Novartis position peaked at $4.41M in Q1 2016.
  • 987 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.